Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Koethe
Vanderbilt University Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Crs (31788)
Birmingham, Alabama, United States
- Ucla Care Center Crs (601)
Los Angeles, California, United States
- Ucsd Antiviral Research Center Crs (701)
San Diego, California, United States
- Ucsf Hiv/aids Crs (801)
San Francisco, California, United States
- Harbor-Ucla Crs (603)
Torrance, California, United States
- University of Colorado Hospital Crs (6101)
Aurora, Colorado, United States
- Whitman-Walker Institute, Inc. Crs (31791)
Washington D.C., District of Columbia, United States
- the Ponce de Leon Center Crs (5802)
Atlanta, Georgia, United States
- Northwestern University Crs (2701)
Chicago, Illinois, United States
- Johns Hopkins University Crs (201)
Baltimore, Maryland, United States
- Brigham and Women'S Hosp. Actg Crs (107)
Boston, Massachusetts, United States
- Massachusetts General Hospital (mgh) Crs (101)
Boston, Massachusetts, United States
- Washington University Therapeutics (wt) Crs (2101)
St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center Crs (31786)
Newark, New Jersey, United States
- Columbia Physicians and Surgeons (p&s) Crs (30329)
New York, New York, United States
- Weill Cornell Chelsea Crs (7804)
New York, New York, United States
- Weill Cornell Upton Crs (7803)
New York, New York, United States
- University of Rochester Adult Hiv Therapeutic Strategies Network Crs (31787)
Rochester, New York, United States
- Chapel Hill Crs (3201)
Chapel Hill, North Carolina, United States
- Greensboro Crs (3203)
Greensboro, North Carolina, United States
- Cincinnati Crs (2401)
Cincinnati, Ohio, United States
- Case Crs (2501)
Cleveland, Ohio, United States
- Ohio State University Crs (2301)
Columbus, Ohio, United States
- Penn Therapeutics Crs (6201)
Philadelphia, Pennsylvania, United States
- Vanderbilt Therapeutics (vt) Crs (3652)
Nashville, Tennessee, United States
- Houston Aids Research Team Crs (31473)
Houston, Texas, United States
- University of Washington Positive Research Crs (1401)
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Jul 2021
- Primary completion
- 18 Oct 2024
- Completion
- 18 Oct 2024
- Last update posted
- 2 Jul 2025
- Registered enrollment
- 147
- Registry id
- NCT04636437
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.